ENTITY

Global Blood Therapeutics (GBT US)

Analysis

Health Care • United States

Global Blood Therapeutics, Inc. operates as a biopharmaceutical company. The Company focuses on discovering, developing, and commercializing therapeutics to treat blood-based disorders. Global Blood Therapeutics serves customers worldwide.

Refresh

Focused

No publications yet

There aren’t any buy-side reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00